ASTH Astrana Health, Inc.

Nasdaq apollomed.net


$ 33.30 nm (nm)    

Tuesday, 04-Nov-2025 16:00:48 EST
QQQ $ 618.74 $ -12.83 (-2.03 %)
DIA $ 471.55 $ -2.57 (-0.54 %)
SPY $ 675.71 $ -8.10 (-1.19 %)
TLT $ 89.97 $ 0.20 (0.22 %)
GLD $ 361.67 $ -6.46 (-1.75 %)
$ 32.99
$ 33.19
$ 31.70 x 100
$ 34.30 x 1
$ 32.74 - $ 33.90
$ 21.20 - $ 60.99
651,542
na
1.85B
$ 1.24
$ 73.22
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-09-2025 03-31-2025 10-Q
3 03-14-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 02-29-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 03-01-2023 12-31-2022 10-K
12 11-07-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 02-28-2022 12-31-2021 10-K
16 11-05-2021 09-30-2021 10-Q
17 08-06-2021 06-30-2021 10-Q
18 05-07-2021 03-31-2021 10-Q
19 03-15-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-29-2020 03-31-2020 10-Q
23 03-16-2020 12-31-2019 10-K
24 11-08-2019 09-30-2019 10-Q
25 08-09-2019 06-30-2019 10-Q
26 05-10-2019 03-31-2019 10-Q
27 03-18-2019 12-31-2018 10-K
28 11-14-2018 09-30-2018 10-Q
29 08-14-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 04-02-2018 12-31-2017 10-K
32 11-14-2017 09-30-2017 10-Q
33 08-14-2017 06-30-2017 10-Q
34 06-29-2017 03-31-2017 10-K
35 02-14-2017 12-31-2016 10-Q
36 11-14-2016 09-30-2016 10-Q
37 08-15-2016 06-30-2016 10-Q
38 06-29-2016 03-31-2016 10-K
39 02-16-2016 12-31-2015 10-Q
40 11-16-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Astrana Health (NASDAQ:ASTH) affirms FY2025 sales outlook from $3.100 billion-$3.300 billion to $3.100 billion-$3.300 billion v...

Core News & Articles

Astrana Health (NASDAQ:ASTH) sees Q3 sales of $925.000 million-$965.000 million vs $761.093 million analyst estimate.

Core News & Articles

Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.3...

Core News & Articles

Astrana Health (NASDAQ:ASTH) sees Q2 sales of $615.000 million-$655.000 million vs $660.68 million analyst estimate.

Core News & Articles

Astrana Health (NASDAQ:ASTH) affirms FY2025 sales outlook from $2.50 billion-$2.70 billion to $2.50 billion-$2.70 billion vs $2...

Core News & Articles

Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.2...

 medicare-advantage-rates-expected-to-climb-over-5-in-2026-easing-pressure-on-managed-care

CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers focused on value-based care.

Core News & Articles

Barclays analyst Andrew Mok initiates coverage on Astrana Health (NASDAQ:ASTH) with a Equal-Weight rating and announces Pric...

Core News & Articles

Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ:ASTH) with a Buy and lowers the price target from...

Core News & Articles

B of A Securities analyst Adam Ron maintains Astrana Health (NASDAQ:ASTH) with a Buy and lowers the price target from $55 to...

Core News & Articles

Baird analyst Michael Ha maintains Astrana Health (NASDAQ:ASTH) with a Outperform and lowers the price target from $86 to $50.

Core News & Articles

Astrana Health (NASDAQ:ASTH) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $0.1...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION